Profile for Portola Pharmaceuticals Inc. (PTLA)

$ 6.48 r      -0.65 (-9.12%) Volume: 1.99m 4:00 PM EDT Apr 1, 2020
After Hours:  $ 6.48 0.00 (0.00%) Volume: 28.12k 5:12 PM EDT Apr 1, 2020
Business Description:
Portola Pharmaceuticals Inc is engaged in the healthcare sector. It develops & commercializes novel therapeutics to combat thrombosis, hematologic disorders & inflammation.
Address: 270 E. Grand Avenue, South San Francisco, CA, USA, 94080
Telephone: +1 650 246-7000 Website: https://www.portola.com
Facsimile: +1 650 246-7376 Email: [email protected]
Details
CEO: Scott Garland
Employees: 408 Market Cap: 505.96m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1269021
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)